Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial
AUTOR(ES)
Arnold, D
FONTE
Nature Publishing Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2768435Documentos Relacionados
- Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
- Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial
- Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor
- Molecular classification of solid tumours: towards pathway-driven therapeutics
- Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial